跳至主要内容
临床试验/NCT03064672
NCT03064672Unknown不适用

Transcervical Balloon Catheters in GBS Carriers, Is It Safe? A Randomized Controlled Trial

Hadassah Medical Organization0 个研究点目标入组 500 人开始时间: 2020年12月最近更新:
适应症

试验速览

阶段
不适用
入组人数
500
主要终点
adverse neonatal outcomes

研究概览

简要总结

This prospective cohort study aims to determine whether maternal and neonatal outcomes are affected by GBS carrier status in women undergoing transcervical balloon catheter insertion.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • During the study period and in the absence of contraindications, women anticipating induction of labor with unripe cervix will be screened for eligibility.
  • Inclusion criteria are singleton gestation with confirmed cephalic presentation
  • Gestational age between 37+0/7 and 41+6/7 weeks'
  • Intact membranes
  • Reactive non-stress test and Bishop's score < 6.

排除标准

  • Women less than 18 years, with multiple gestation pregnancies, pregnancies with major fetal anomalies, vaginal infection, intrauterine fetal death and those who were not candidates for vaginal delivery (placenta previa, non-cephalic presentation, planned cesarean delivery).

结局指标

主要结局

adverse neonatal outcomes

时间窗: 2-3 days

the incidence of composite adverse neonatal outcomes based on the NICE criteria for early detection of neonatal sepsis

次要结局

  • composite adverse maternal outcomes(2-3 days)

研究者

申办方类型
Other
责任方
Sponsor

相似试验